Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 30 May 2006):
Free Full Text!
See links below

Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma.

Full Abstract

Mycosis fungoides and its leukemic variant, Sezary syndrome, are the most common primary cutaneous T-cell lymphomas (CTCLs). In an ex vivo study, we investigated the percentage, phenotype, and suppressive function of CD4+CD25+ regulatory T cells (Tregs) from peripheral blood of CTCL patients. The percentage of Tregs did not differ significantly between patients and controls. Functional assays demonstrated a dichotomy in Treg function:
in four out of 10 patients CD4+CD25+ T cells were incapable of suppressing autologous CD4+CD25- T-cell proliferation, whereas suppressive function was intact in the other six patients. Suppressive activity of Tregs inversely correlated with the peripheral blood tumor burden. T-plastin gene expression, used as a Sezary cell marker, confirmed that Sezary cells were heterogeneous for CD25 expression. Mixed lymphocyte reactions demonstrated that CD4+CD25- T cells from patients who lacked functional Tregs were susceptible to suppression by Tregs from healthy controls, and had not become suppressive themselves. Furthermore, we found reduced expression of Foxp3 in the CD4+CD25+ Tregs of these patients relative to the other six CTCL patients and controls. Our findings thus indicate a dysfunction of peripheral Tregs in certain CTCL patients, which correlates with tumor burden.

 

Learn Faster Today      Improve your study skills

Author information

Author/s: Tiemessen, Machteld M (MM); Mitchell, Tracey J (TJ); Hendry, Lisa (L); Whittaker, Sean J (SJ); Taams, Leonie S (LS); John, Susan (S);

Affiliation: Immunobiology Department, Division of Immunology, Infection and Inflammatory Disease, King's College London School of Medicine at Guy's, King's College and St Thomas' Hospitals, London, UK.

Grants: (Agency:Wellcome Trust)

Journal and publication information

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal: The Journal of investigative dermatology (J Invest Dermatol), published in United States. (Language: eng)

Reference: 2006-Oct; vol 126 (issue 10) : pp 2217-23

Dates: Created 2006/09/19; Completed 2006/10/26; Revised 2007/08/13;

PMID: 16741512, status: MEDLINE (last retrieval date: 12/26/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Antigens, CD (0) ; Antigens, Differentiation (0) ; FOXP3 protein, human (0) ; Forkhead Transcription Factors (0) ; RNA, Messenger (0) ; cytotoxic T-lymphocyte antigen 4 (0)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

4/29/1992
9/29/2008
Higher Relevance Score (24)
Lower Relevance Score (16)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy.com 2003-2009 (ACN 104 198 263) - All rights reserved. Terms of Use | Contact Us | Index